Institute of Metabolic Disease

Dallas, Texas 75246

0 studies enrolling now · 3 studies all time

What they study most

Fabry Disease

Studies at this site

• Open Label Extension Study of 1 mg/kg Pegunigalsidase Alfa Every 2 Weeks in Patients With Fabry Disease — Completed
• Extension Study of PRX-102 for up to 60 Months — Completed
• Safety, Efficacy, & PK of PRX-102 in Patients With Fabry Disease Administered Intravenously Every 4 Weeks — Completed